Direct 2U E Cigs

2 weeks ago

Now in store and online The all New OBS CUBE MESH KIT SEE LINK

www.direct2uecigs.ie/online-vaping-shop/mods/obs-cube-mesh-kit/ ... See MoreSee Less

Direct 2U E Cigs

2 months ago

Last week some big news was released! The World Health Organisation finally released their recommendations on cannabis. Looks like it will bring big changes for CBD very soon.

Keep reading for all the details!

3 Ways the WHO Clears the Way for CBD
The World Health Organisation is about more than just public health initiatives. They are changing the future of the cannabis industry.

In the CBD industry, you have to do more than just keep your ear to the ground on what's happening in regulation.

You can only get ahead if you stay on top of them since even small changes can endanger your business at any moment. That's how you can become a market leader—or at least sell more products!

But as anyone who's ever tried to keep up with changing laws can tell you, it isn't easy.

Sometimes you need a helping hand to guide you through the complexity.

The World Health Organisation just released a series of surprising new developments. Unsurprisingly, they aren’t easy to understand. So, here are 3 easy-to-understand ways the WHO just fast-tracked your path to CBD profits.

1. “Deleting” Cannabis Means Times are Changing
The World Health Organisation Expert Committee on Drug Dependence (ECDD) finally released their recommendations on cannabis. The UN Commission on Narcotic Drugs (CND) expected to pass new scheduling on cannabis in early March 2019 but has been waiting on the WHO’s formal recommendations.

The report recommends cannabis and cannabis resin “be deleted from Schedule IV of the Single Convention on Narcotics Drugs (1961).” This moves cannabis to Schedule I—significantly freeing access, research, and development.

2. Pure CBD “Not Included” in Any International Drug Convention
In December 2017, the WHO said cannabidiol (CBD) is safe, produces no “high,” and there exists “no evidence of public health...problems.” This new report takes our understanding further.

The ECDD recommends that all pure CBD and CBD products containing under 0.2% THC would not be included in any international drug control conventions.

Because “cannabidiol found in cannabis and cannabis resin does not have psychoactive properties and has no potential for abuse and no potential to produce dependence.” This is great news for the CBD industry worldwide!

3. Significantly Simplifying Cannabis
THC in all forms would be removed from the 1971 Convention and placed with cannabis in Schedule I of the 1961 Convention. Grouping all forms of THC in the same category as cannabis and cannabis resin makes classifying cannabis tremendously simpler.

The ECDD said two important things that make this possible:

The dangers associated with THC are similar to those of cannabis and cannabis resin, so having them all together in the same category is a matter of consistency.

Grouping all THC isomers makes sense when they are difficult to differentiate from each other through standard analysis.

The report provides an example of this disintegration of distinctions in its recommendation to delete extracts and tinctures of cannabis from Schedule I of the Single Convention on Narcotics Drugs (1961).

What This Means For You

With the WHO’s new report, member states can now review and discuss the considerations before making a formal change. With renewed clarity for March 2019, any new scheduling by the UN will inevitably bring exciting new opportunities to the exploding CBD industry.

The stage is set for the age of cannabis to truly begin in Europe.

-----------------
click on link

www.direct2uecigs.ie/brand/cannabidiol-cbd-e-liquid/ ... See MoreSee Less